Results 71 to 80 of about 132,650 (237)
Genetic polymorphism of cytochrome p450 (2C19) enzyme in Iranian Turkman ethnic group [PDF]
, 2013 Objective: Different findings indicate that CYP2C plays a clinical role in determining interindividual and interethnic differences in drug effectiveness. The ethnic differences in the frequency of CYP2C19 mutant alleles continue to be a significant study
Ataby, O.A. +4 more
core +2 more sources
The Medicare Part D Coverage Gap: Costs and Consequences in 2007 [PDF]
, 2008 Analyzes data on Medicare Part D enrollees who reached the coverage gap and had to pay the full cost until they qualified for catastrophic coverage, who then stopped taking their medications or bought cheaper ones, and who received catastrophic ...
Elizabeth Hargrave +3 more
core
Journal of the Pakistan Medical AssociationObjective: To evaluate serum prolactin and macroprolactin levels in patients on long-term proton pump inhibitors therapy. Method: The cross-sectional study was conducted from January 2018 to November 2019 after approval from the ethics review ...
Muhammad Ashfaq +3 more
doaj +1 more source
Association between Proton Pump Inhibitors Use and Spontaneous Bacterial Peritonitis Development in Egyptian Cirrhotic Patients with Ascites [PDF]
, 2022 Walaa El-Sayed +3 more
openalex +1 more source
Research of the assortment of the proton pump inhibitors on the regional drugs market
RUDN Journal of Medicine, 2013 Proton pump inhibitors are new most effective remedies for the treatment of gastric ulcer and duodenal ulcer. Analysis results of proton pump inhibitors assortment on the regional market are presented in the article.
O G Ivchenko +4 more
doaj
Pharmacogenetics of proton pump inhibitors
Медицинский совет, 2015 Proton pump inhibitors (PPI) are currently the most effective class of antisecretory drugs widely used in the treatment of non-ulcer dyspepsia, reflux esophagitis and GERD, peptic ulcer disease and H. pilory infection, as well as NSAID-associated gastric
M. V. Leonova
doaj +1 more source
RENAL SAFETY OF PROTON PUMP INHIBITORS
Архивъ внутренней медицины, 2017 Proton pump inhibitors are a widely used in clinical practice, and are taken by millions of patients around the world for a long time. While proton pump inhibitors are well-tolerated class of drugs, the number of publications has been raised about ...
A. I. Dyadyk, T. E. Kugler
doaj +1 more source
Degradation of lansoprazole and omeprazole in the aquatic environment [PDF]
, 2006 Lansoprazole and omeprazole degrade in water leading to sulfides, benzimidazolones and a red complex material. Degradation is accelerated in acid medium and by solar simulator irradiation.
BRIGANTE M. +5 more
core +1 more source
Safety of proton pump inhibitors
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2016 Aim of review. To present modern data on the possible mechanisms of development of side effects of the proton pump inhibitors (PPI). Summary. Proton pump inhibitors is the class of pharmaceuticals that block N+/K+-ATPase of gastric parietal cells.
Ye. A. Losik
doaj +1 more source
A new type of Na+-driven ATP synthase membrane rotor with a two-carboxylate ion-coupling motif [PDF]
, 2013 : The anaerobic bacterium Fusobacterium nucleatum uses glutamate decarboxylation to generate a transmembrane gradient of Na+. Here, we demonstrate that this ion-motive force is directly coupled to ATP synthesis, via an F1Fo-ATP synthase with a novel Na ...
Faraldo-Gómez, José D. +8 more
core +3 more sources